|
|
|
|
| LEADER |
03772nmm a2200985 u 4500 |
| 001 |
EB002165151 |
| 003 |
EBX01000000000000001302930 |
| 005 |
00000000000000.0 |
| 007 |
cr||||||||||||||||||||| |
| 008 |
230607 ||| eng |
| 020 |
|
|
|a 9780841210134
|
| 050 |
|
4 |
|a RS431.M45
|
| 100 |
1 |
|
|a Lippard, Stephen J.
|e [editor]
|
| 245 |
0 |
0 |
|a Platinum, gold, and other metal chemotherapeutic agents
|b chemistry and biochemistry
|c Stephen J. Lippard, editor
|
| 260 |
|
|
|a Washington, DC
|b American Chemical Society
|c 1983, 1983
|
| 300 |
|
|
|a 468 pages
|b illustrations
|
| 505 |
0 |
|
|a Includes bibliographical references and index
|
| 653 |
|
|
|a Pharmaceutical chemistry
|
| 653 |
|
|
|a Neutron Activation Analysis
|
| 653 |
|
|
|a MEDICAL / Pharmacology / bisacsh
|
| 653 |
|
|
|a Osmium Compounds / therapeutic use
|
| 653 |
|
|
|a Simian virus 40
|
| 653 |
|
|
|a Dimethyl sulfoxide
|
| 653 |
|
|
|a Oligonucleotides
|
| 653 |
|
|
|a Anti-Inflammatory Agents
|
| 653 |
|
|
|a Chemistry, Pharmaceutical
|
| 653 |
|
|
|a TECHNOLOGY & ENGINEERING / Biomedical / bisacsh
|
| 653 |
|
|
|a Oligonucleotides / Experiments
|
| 653 |
|
|
|a Antiarthritic agents
|
| 653 |
|
|
|a Electron Probe Microanalysis
|
| 653 |
|
|
|a Cisplatin
|
| 653 |
|
|
|a Organometallic Compounds / therapeutic use
|
| 653 |
|
|
|a X-Rays
|
| 653 |
|
|
|a Gold / therapeutic use
|
| 653 |
|
|
|a Microprobe analysis / Utilization
|
| 653 |
|
|
|a Thymopoietins
|
| 653 |
|
|
|a Gold Compounds / therapeutic use
|
| 653 |
|
|
|a Purine Nucleosides
|
| 653 |
|
|
|a Nuclear activation analysis / Utilization
|
| 653 |
|
|
|a X-Ray Absorption Spectroscopy
|
| 653 |
|
|
|a X-ray absorption near edge structure / Utilization
|
| 653 |
|
|
|a DNA.
|
| 653 |
|
|
|a Purine nucleosides
|
| 653 |
|
|
|a Antineoplastic agents / Experiments
|
| 653 |
|
|
|a Thiols
|
| 653 |
|
|
|a Gold compounds / Therapeutic use / Models
|
| 653 |
|
|
|a Nucleotides
|
| 653 |
|
|
|a Ruthenium / therapeutic use
|
| 653 |
|
|
|a Arthritis / drug therapy
|
| 653 |
|
|
|a Metallocenes / therapeutic use
|
| 653 |
|
|
|a DNA Adducts / analysis
|
| 653 |
|
|
|a Anti-Inflammatory Agents / therapeutic use
|
| 653 |
|
|
|a Dimethyl Sulfoxide
|
| 653 |
|
|
|a Ruthenium / Therapeutic use
|
| 653 |
|
|
|a Metals / Therapeutic use
|
| 653 |
|
|
|a SV40 (Virus)
|
| 653 |
|
|
|a Antineoplastic agents
|
| 653 |
|
|
|a Pyrimidines
|
| 653 |
|
|
|a Sulfhydryl Compounds
|
| 653 |
|
|
|a Inventions
|
| 653 |
|
|
|a Antineoplastic Agents
|
| 653 |
|
|
|a Metallocenes / Therapeutic use
|
| 653 |
|
|
|a DNA adducts / Formation
|
| 653 |
|
|
|a Platinum compounds / Therapeutic use / Technological innovations
|
| 653 |
|
|
|a DNA adducts / Structure / Analysis
|
| 653 |
|
|
|a Osmium compounds / Therapeutic use
|
| 653 |
|
|
|a Purines
|
| 653 |
|
|
|a Platinum Compounds / therapeutic use
|
| 653 |
|
|
|a Platinum / therapeutic use
|
| 653 |
|
|
|a DNA Adducts
|
| 653 |
|
|
|a Platinum compounds / Therapeutic use
|
| 653 |
|
|
|a Extended X-ray absorption fine structure / Utilization
|
| 653 |
|
|
|a Thymine
|
| 653 |
|
|
|a Metals / therapeutic use
|
| 653 |
|
|
|a Organometallic compounds / Therapeutic use
|
| 653 |
|
|
|a Gold compounds / Therapeutic use
|
| 653 |
|
|
|a Uracil
|
| 710 |
2 |
|
|a American Chemical Society
|b Division of Inorganic Chemistry
|
| 710 |
2 |
|
|a American Chemical Society
|b Meeting ( 1982, Las Vegas, Nevada)
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b ACS
|a ACS Symposium Series
|
| 490 |
0 |
|
|a ACS symposium series
|
| 500 |
|
|
|a "Based on a symposium sponsored by the ACS Division of Inorganic Chemistry at the 183rd Meeting of the American Chemical Society, Las Vegas, Nevada, March 28-April 2, 1982.". - Distributed in print by Oxford University Press
|
| 856 |
4 |
0 |
|u https://pubs.acs.org/doi/book/10.1021/bk-1983-0209
|x Verlag
|3 Volltext
|
| 082 |
0 |
|
|a 616.99/4061
|